{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:09:42Z","timestamp":1779199782073,"version":"3.51.4"},"reference-count":36,"publisher":"American Society for Clinical Investigation","issue":"19","funder":[{"name":"Biomedical Research Council of Singapore","award":["13\/1\/96\/19\/689"],"award-info":[{"award-number":["13\/1\/96\/19\/689"]}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["MH095:003\/008-194"],"award-info":[{"award-number":["MH095:003\/008-194"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["NMRC\/STaR\/020\/2013"],"award-info":[{"award-number":["NMRC\/STaR\/020\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["NMRC\/MOHIAFCAT2\/005\/2015"],"award-info":[{"award-number":["NMRC\/MOHIAFCAT2\/005\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["MOHIAFCAT2001"],"award-info":[{"award-number":["MOHIAFCAT2001"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["CIRG13nov032"],"award-info":[{"award-number":["CIRG13nov032"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["NMRC MOHIAFCAT1-6003"],"award-info":[{"award-number":["NMRC MOHIAFCAT1-6003"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["NMRC\/CSA-INV\/0013\/2016"],"award-info":[{"award-number":["NMRC\/CSA-INV\/0013\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council of Singapore","doi-asserted-by":"crossref","award":["NMRC\/CSA\/060\/2014"],"award-info":[{"award-number":["NMRC\/CSA\/060\/2014"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,5]]},"abstract":"<jats:p>The innate immune response shapes the development of adaptive immunity following infections and vaccination. However, it can also induce symptoms such as fever and myalgia, leading to the possibility that the molecular basis of immunogenicity and reactogenicity of vaccination are inseparably linked. To test this possibility, we used the yellow fever live-attenuated vaccine (YFLAV) as a model to study the molecular correlates of reactogenicity or adverse events (AEs). We analyzed the outcome of 68 adults who completed a YFLAV clinical trial, of which 43 (63.2%) reported systemic AEs. Through whole-genome profiling of blood collected before and after YFLAV dosing, we observed that activation of innate immune genes at day 1, but not day 3 after vaccination, was directly correlated with AEs. These findings contrast with the gene expression profile at day 3 that we and others have previously shown to be correlated with immunogenicity. We conclude that although the innate immune response is a double-edged sword, its expression that induces AEs is temporally distinct from that which engenders robust immunity. The use of genomic profiling thus provides molecular insights into the biology of AEs that potentially forms a basis for the development of safer vaccines.<\/jats:p>","DOI":"10.1172\/jci.insight.96031","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T11:00:45Z","timestamp":1507114845000},"source":"Crossref","is-referenced-by-count":27,"title":["Early molecular correlates of adverse events following yellow fever vaccination"],"prefix":"10.1172","volume":"2","author":[{"given":"Candice Y.Y.","family":"Chan","sequence":"first","affiliation":[{"name":"Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore."},{"name":"Department of Infectious Diseases, Singapore General Hospital, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan Rong","family":"Chan","sequence":"additional","affiliation":[{"name":"Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillus J.H.","family":"Chua","sequence":"additional","affiliation":[{"name":"SingHealth Translational Immunology and Inflammation Centre (STIIC), Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharifah","family":"nur Hazirah","sequence":"additional","affiliation":[{"name":"SingHealth Translational Immunology and Inflammation Centre (STIIC), Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Centre for Computational Biology, Duke-NUS Medical School, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[{"name":"Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore."},{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"Saw Swee Hock School of Public Health, National University of Singapore, Singapore."},{"name":"Interdisciplinary Research Group in Infectious Diseases, Singapore-MIT Alliance for Research & Technology (SMART), Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny G.","family":"Low","sequence":"additional","affiliation":[{"name":"Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore."},{"name":"Department of Infectious Diseases, Singapore General Hospital, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1038249"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082292"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1688"},{"key":"B5"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700083"},{"issue":"10","key":"B7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2297"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.12.026"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-89102005000300012"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.533"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.1045"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.2.5216"},{"issue":"3","key":"B15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2005.72.339","article-title":"Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"B16","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events version 4.03 (CTCAE). US Department of Health and Human Services, National Institute of Health, National Cancer Institute; 2010. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf NCI Website. Published May 28, 2009. Updated June 14, 2010. Accessed September 4, 2017"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38248"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2234"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3946"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.4"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2015.09.001"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1039\/C6MB00600K"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.06.003"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1186\/1755-8794-2-38","article-title":"A gene signature for post-infectious chronic fatigue syndrome","volume":"2","author":"Gow","year":"2009","journal-title":"BMC Med Genomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-1-10"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05122.x"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.10.040"},{"issue":"8","key":"B29","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjp.2008.204","article-title":"Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders","volume":"154","author":"Jensen","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4337"},{"issue":"Database issue","key":"B31","doi-asserted-by":"crossref","first-page":"D832","DOI":"10.1093\/nar\/gkn835","article-title":"AutDB: a gene reference resource for autism research","volume":"37","author":"Basu","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.09.009"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1086\/315215"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000657"},{"key":"B35"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61208-3"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/96031\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:33:06Z","timestamp":1779197586000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/96031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":36,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2017,10,5]]},"published-print":{"date-parts":[[2017,10,5]]}},"alternative-id":["10.1172\/jci.insight.96031"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.96031","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]},"article-number":"e96031"}}